Back to Awarded Treatment Trials


Awarded Trial: 02I-007

Grant ID

02I-007

Illness

Schizophrenia

Primary Drug/Intervention

Tianma (gastrodia elata B1.)

Primary Dosage

800 mg/tid

Secondary Drug Intervention

N/A

Secondary Dosage

N/A

Other Drug/Intervention

N/A

Other Dosage

N/A

Status

Completed

Investigator

Ma

Sample Size

200

Duration of Study Period for Each Subject

8 weeks

Outcome Measurements

PANSS, BPRS

Results

A significantly greater percentage of patients receiving Tianma were classified as "clinical cures". Patients receiving Tianma also demonstrated a significant reduction in the PANSS total score reduction ratio, and the PANSS positive score reduction ratio.

Publication

N/A

Link

N/A

PI Name

Ping Ma

Degree

MD

Center

Immunology Laboratory

Institution

Chengdu University

Address

#37, 12th Bridge Road

City or Town

Chengdu

State or Province

Sichuan

Zip or Postal Code

610075

Country

China

Email Address

mmpp@vip.sina.com